Synthetic organic

foslinanib.

foslinanib.

fosphenytoin.

fosphenytoin.

Fostamatinib (R788), a prodrug of the active metabolite R406, is a Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 3.An inhibitor to spleenic kinase-mediated IgG Fc receptor signaling.

Fostamatinib (R788), a prodrug of the active metabolite R406, is a Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 3.An inhibitor to spleenic kinase-mediated IgG Fc receptor signaling.

Fostamatinib (R788), a prodrug of the active metabolite R406, is a Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 3.An inhibitor to spleenic kinase-mediated IgG Fc receptor signaling.

Fostamatinib (R788), a prodrug of the active metabolite R406, is a Syk inhibitor with IC50 of 41 nM, strongly inhibits Syk but not Lyn, 5-fold less potent to Flt3. Phase 3.An inhibitor to spleenic kinase-mediated IgG Fc receptor signaling.

FP0429.

FP0429.

Potent CaV1.x activator.

Potent CaV1.x activator.